<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A series of novel <z:chebi fb="0" ids="36481">oleanane</z:chebi>-type <z:chebi fb="0" ids="25872">pentacyclic triterpenoids</z:chebi> bearing a <z:chebi fb="0" ids="50979">boronate ester</z:chebi> moiety at C3 have been synthesized by <z:chebi fb="79" ids="33363">palladium</z:chebi>-catalyzed cross-coupling of bis(pinacolato)<z:chebi fb="0" ids="51707">diboron</z:chebi> with vinyl <z:chebi fb="0" ids="48547">triflates</z:chebi>, in the presence of base, and these compounds were fully characterized by 1D and 2D NMR techniques </plain></SENT>
<SENT sid="1" pm="."><plain>Evaluation of their antiproliferative effects on a panel of hematological-based and <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumor</z:e> cell lines identified three active oleanolic <z:chebi fb="0" ids="50980">vinyl boronates</z:chebi> that inhibited the growth of <z:hpo ids='HP_0001909'>leukemia</z:hpo> (Jurkat, K562), Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (Jijoye), cervix (Hela), colon (SW480), and ovary (SKOV-3) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells without concomitant inhibition of non-tumoral human fibroblasts </plain></SENT>
<SENT sid="2" pm="."><plain>Their mechanisms of action were investigated on the <z:hpo ids='HP_0001909'>leukemia</z:hpo> Jurkat cell line </plain></SENT>
<SENT sid="3" pm="."><plain>The results show that the incorporation of <z:chebi fb="19" ids="27560,33609,51707">boron</z:chebi> in the <z:chebi fb="0" ids="37659">oleanolic acid</z:chebi> core combined with the presence of <z:chebi fb="0" ids="29337,32988">amide</z:chebi> bonds afforded compounds with desirable biological effects such as <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induction and inhibition of proteasomal activity on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, which makes them potential templates for further development in the anticancer drug setting </plain></SENT>
</text></document>